157 related articles for article (PubMed ID: 11602857)
21. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
22. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
25. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
26. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
27. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
28. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.
Larsen CP; Alexander DZ; Hollenbaugh D; Elwood ET; Ritchie SC; Aruffo A; Hendrix R; Pearson TC
Transplantation; 1996 Jan; 61(1):4-9. PubMed ID: 8560571
[TBL] [Abstract][Full Text] [Related]
29. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
[TBL] [Abstract][Full Text] [Related]
30. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
Honey K; Cobbold SP; Waldmann H
J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
[TBL] [Abstract][Full Text] [Related]
31. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
[TBL] [Abstract][Full Text] [Related]
33. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
[TBL] [Abstract][Full Text] [Related]
34. Role of CD28 in acute graft-versus-host disease.
Yu XZ; Martin PJ; Anasetti C
Blood; 1998 Oct; 92(8):2963-70. PubMed ID: 9763584
[TBL] [Abstract][Full Text] [Related]
35. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival.
Szot GL; Zhou P; Sharpe AH; He G; Kim O; Newell KA; Bluestone JA; Thistlethwaite JR
Transplantation; 2000 Mar; 69(5):904-9. PubMed ID: 10755548
[TBL] [Abstract][Full Text] [Related]
36. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
37. Roles of CD4+ and CD8+ T cells in discordant skin xenograft rejection.
Uchida T; Tomita Y; Anzai K; Zhang QW; Yoshikawa M; Kishihara K; Nomoto K; Yasui H
Transplantation; 1999 Dec; 68(11):1721-7. PubMed ID: 10609949
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
Clement JD; Chan SY; Bishop DK
Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
[TBL] [Abstract][Full Text] [Related]
39. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
[TBL] [Abstract][Full Text] [Related]
40. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
Subbotin V; Sun H; Chen C; Aitouche A; Valdivia L; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1998 Jun; 30(4):941-2. PubMed ID: 9636378
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]